Kontakt 2020, 22(2):128-136 | DOI: 10.32725/kont.2020.019

Health-related quality of life measures for a cost-effectiveness analysis of ischemic stroke therapiesSocial Sciences in Health - Original article

Irena Drugdová1, Vladimír Rogalewicz1, Martin Šrámek2, Veronika Kopalová3, Ondřej Krahula4, Beáta Gavurová5, Miroslav Barták5,*
1 Czech Technical University in Prague, CzechHTA, Faculty of Biomedical Engineering, Department of Biomedical Technology, Kladno, Czech Republic
2 Military University Hospital, Comprehensive Stroke Center, Prague, Czech Republic, and Charles University and Motol University Hospital, Second Faculty of Medicine, Department of Neurology, Prague, Czech Republic
3 Military University Hospital, Controlling Department, Prague, Czech Republic
4 Military University Hospital, Department of Radiology, Prague, Czech Republic
5 Charles University and General University Hospital in Prague, First Faculty of Medicine, Department of Addictology, Prague 2, Czech Republic

Stroke treatment and prevention has witnessed a dramatic development in recent years, especially in developed countries. The objective of this study was to calculate the costs and cost effectiveness of the treatment of ischemic stroke in a Czech stroke center using semi-objective neurological measures - the modified Rankin Score (mRS), the National Institute of Health Stroke Scale (NIHSS), and the Modified Thrombolysis In Cerebral Infarction Scale (mTICI). Three possible interventions were investigated: intravenous thrombolysis, neurointerventional radiology, and both interventions applied in succession. In terms of both short-term and long-term effects, from the hospital as well as the health insurance company perspective, the most cost-effective intervention proved to be intravenous thrombolysis - for patients with both less and more severe stroke. This corresponds to the results of our literature search. The study supports the suitability of the chosen HRQoL measures for analyses of clinical effectiveness and cost-effectiveness of stroke therapies. In stroke patients, mRS, NIHSS, mTICI are more stable and have a better predictive value than QALYs based on patient-reported values.

Keywords: Acute ischemic stroke; Cost-effectiveness; Health technology assessment; HRQoL Specific tools; Thrombectomy; Thrombolysis

Received: January 8, 2020; Revised: March 13, 2020; Accepted: April 27, 2020; Prepublished online: April 30, 2020; Published: May 6, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drugdová I, Rogalewicz V, Šrámek M, Kopalová V, Krahula O, Gavurová B, Barták M. Health-related quality of life measures for a cost-effectiveness analysis of ischemic stroke therapies. Kontakt. 2020;22(2):128-136. doi: 10.32725/kont.2020.019.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Béjot Y, Bailly H, Durier J, Giroud M (2016). Epidemiology of stroke in Europe and trends for the 21st century. Presse Med 45(12): E391-E398. DOI: 10.1016/j.lpm.2016.10.003. Go to original source... Go to PubMed...
    2. Beresniak A, Medina-Lara A, Auray J, De Wever A, Praet J, Tarricone R, et al. (2015). Validation of the Underlying Assumptions of the Quality-Adjusted Life-Years Outcome: Results from the ECHOUTCOME European Project. Pharmacoeconomics 33(1): 61-69. DOI: 10.1007/s40273-014-0216-0. Go to original source... Go to PubMed...
    3. Berkhemer OA, Fransen PSS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. (2015). A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke. N Engl J Med 372(1): 11-20. DOI: 10.1056/NEJMoa1411587. Go to original source... Go to PubMed...
    4. Bracard S, Ducrocq X, Mas JL, Soudant M, Oppenheim C, Moulin T, Guillemin F (2016). Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol 15(11): 1138-1147. DOI: 10.1016/s1474-4422(16)30177-6. Go to original source... Go to PubMed...
    5. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al. (2013). Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke. N Engl J Med 368(10): 893-903. DOI: 10.1056/NEJMoa1214300. Go to original source... Go to PubMed...
    6. Campbell BCV, Donnan GA, Lees KR, Hacke W, Khatri P, Hill MD, et al. (2015). Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke. Lancet Neurol 14(8): 846-854. DOI: 10.1016/s1474-4422(15)00140-4. Go to original source... Go to PubMed...
    7. Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Yan B, et al. (2018). Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study. Int J Stroke 13(3): 328-334. DOI: 10.1177/1747493017733935. Go to original source... Go to PubMed...
    8. Carvalho A, Cunha A, Rodrigues M, Figueiredo S, Paredes L, Gregório T, et al. (2017). Mechanical Thrombectomy in Acute Ischemic Stroke: Initial Single-Center Experience and Comparison with Randomized Controlled Trials. J Stroke Cerebrovasc Dis 26(3): 589-594. DOI: 10.1016/j.jstrokecerebrovasdis.2016.11.116. Go to original source... Go to PubMed...
    9. Chiumente M, Gianino MM, Minniti D, Mattei TJ, Spass B, Kamal KM, et al. (2015). Burden of stroke in Italy: An economic model highlights savings arising from reduced disability following thrombolysis. Int J Stroke 10(6): 849-855. DOI: 10.1111/ijs.12481. Go to original source... Go to PubMed...
    10. Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, Boccardi E (2013). Endovascular Treatment for Acute Ischemic Stroke. N Eng J Med 368(10): 904-913. DOI: 10.1056/NEJMoa1213701. Go to original source... Go to PubMed...
    11. Donaldson L, Fitzgerald E, Flower O, Delaney A (2016). Review article: Why is there still a debate regarding the safety and efficacy of intravenous thrombolysis in the management of presumed acute ischaemic stroke? A systematic review and meta-analysis. Emerg Med Australas 28(5): 496-510. DOI: 10.1111/1742-6723.12653. Go to original source... Go to PubMed...
    12. Drugdová I (2018). Klinická a nákladová efektivita léčby cévní mozkové příhody v Komplexním cerebrovaskulárním centru. (Master Thesis). Kladno: České vysoké učení technické v Praze.
    13. EUnetHTA (2015). Methods for health economic evaluations - A guideline based on current practices in Europe. [online] [cit. 2019-04-16]. Available from: https://eunethta.eu/wp-content/uploads/2018/03/Methods_for_health_economic_evaluations.pdf
    14. Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, et al. (2016). Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol 15(9): 913-924. DOI: 10.1016/s1474-4422(16)30073-4. Go to original source... Go to PubMed...
    15. Ganesalingam J, Pizzo E, Morris S, Sunderland T, Ames D, Lobotesis K (2015). Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke. Stroke 46(9): 2591-2598. DOI: 10.1161/strokeaha.115.009396. Go to original source... Go to PubMed...
    16. Hamann GF, Müller R, Alber B, Widder B (2016). Treatment in acute stroke - Stroke unit is mandatory. Neurology Psychiatry and Brain Research 22(2): 105-109. DOI: 10.1016/j.npbr.2015.12.064. Go to original source...
    17. Katan M, Luft A (2018). Global Burden of Stroke. Semin Neurol 38(2): 208-211. DOI: 10.1055/s-0038-1649503. Go to original source... Go to PubMed...
    18. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et al. (2013). A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke. N Engl J Med 368(10): 914-923. DOI: 10.1056/NEJMoa1212793. Go to original source... Go to PubMed...
    19. Kumar G, Uhrig D, Fowler S, DeLaney MC, Alexandrov AV (2015). Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. CNS Drugs 29(8): 659-667. DOI: 10.1007/s40263-015-0265-8. Go to original source... Go to PubMed...
    20. Ministry of Health of the Czech Republic (2010). Péče o pacienty s cerebrovaskulárním onemocněním v České republice [Care of patients with cerebrovascular disease in the Czech Republic]. Věstník MZ ČR, No. 2: 2-13.
    21. Ministry of Health of the Czech Republic (2015). Seznam center vysoce specializované péče o pacienty s iktem [List of highly specialized centers for the care of patients after acute stroke]. Věstník MZ ČR, No. 11: 52-56.
    22. Moore JM, Griessenauer CJ, Gupta R, Adeeb N, Patel AS, Ogilvy CS, Thomas AJ (2016). Landmark papers in
    23. cerebrovascular neurosurgery 2015. Clin Neurol Neurosurg 148: 22-28. DOI: 10.1016/j.clineuro.2016.06.007. Go to original source... Go to PubMed...
    24. Nam J, Jing H, O'Reilly D (2015). Intra-arterial thrombolysis vs. standard treatment or intravenous thrombolysis in adults with acute ischemic stroke: a systematic review and meta-analysis. Int J Stroke 10(1): 13-22. DOI: 10.1111/j.1747-4949.2012.00914.x. Go to original source... Go to PubMed...
    25. Pettitt DA, Raza S, Naughton B, Roscoe A, Ramakrishnan A, Ali A, et al. (2016). The Limitations of QALY: A Literature Review. J Stem Cell Res Ther 6(4): 1000334. DOI: 10.4172/2157-7633.1000334. Go to original source...
    26. Phan K, Zhao DF, Phan S, Huo YR, Mobbs RJ, Rao PJ, Mortimer AM (2016). Endovascular therapy including thrombectomy for acute ischemic stroke: A systematic review and meta-analysis with trial sequential analysis. J Clin Neurosci 29: 38-45. DOI: 10.1016/j.jocn.2015.12.025. Go to original source... Go to PubMed...
    27. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. (2018). 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 49(3): e46-e110. DOI: 10.1161/STR.0000000000000158. Go to original source... Go to PubMed...
    28. Qureshi AI, Miley JT, Chaudhry SA, Semaan E, Rodriguez GJ, Suri MFK, Adams HP (2013). Safety and Effectiveness of Endovascular Treatment after 6 Hours of Symptom Onset in Patients with Anterior Circulation Ischemic Stroke: A Matched Case Control Study. J Stroke Cerebrovasc Dis 22(7): 1076-1081. DOI: 10.1016/j.jstrokecerebrovasdis.2012.07.015. Go to original source... Go to PubMed...
    29. Rodrigues FB, Neves JB, Caldeira D, Ferro JM, Ferreira JJ, Costa J (2016). Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ 353. DOI: 10.1136/bmj.i1754. Go to original source... Go to PubMed...
    30. Rogalewicz V, Bartak M, Kubatova I (2015). Quality and Availability of Cost Data in Czech HTA Research. Central European Conference in Finance and Economics (CEFE2015), 548-560.
    31. Sedova P, Brown RD, Zvolsky M, Kadlecova P, Bryndziar T, Kubelka T, et al. (2017). Incidence of Hospitalized Stroke in the
    32. Muir KW, Weir CJ, Murray GD, Povey C, Lees KR (1996). Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 27(10): 1817-1820. DOI: 10.1161/01.str.27.10.1817. Go to original source... Go to PubMed...
    33. Czech Republic: The National Registry of Hospitalized Patients. J Stroke Cerebrovasc Dis 26(5): 979-986. DOI: 10.1016/j.jstrokecerebrovasdis.2016.11.006. Go to original source... Go to PubMed...
    34. Šrámek M (2016). Akutní léčba ischemické CMP [Ischemic stroke acute treatment] (https://slideplayer.cz/slide/11257648/). In (p. 57). Prague: Neurological Department, Military University Hospital.
    35. Tinková M, Malý P (2016). Nová éra endovaskulární terapie v léčbě akutních iktů [The new era of endovascular therapy in the treatment of acute stroke]. Česká a slovenská neurologie a neurochirurgie 79(2): 152-159.
    36. Wilson JTL, Hareendran A, Grant M, Baird T, Schulz UGR, Muir KW, Bone I (2002). Improving the assessment of outcomes in stroke - Use of a structured interview to assign grades on the modified Rankin Scale. Stroke 33(9): 2243-2246. DOI: 10.1161/01str000002743722450bd. Go to original source... Go to PubMed...
    37. Xie X, Lambrinos A, Chan B, Dhalla IA, Krings T, Casaubon LK, et al. (2016). Mechanical thrombectomy in patients with acute ischemic stroke: a cost-utility analysis. CMAJ Open 4(2): E316-325. DOI: 10.9778/cmajo.20150088. Go to original source... Go to PubMed...
    38. Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL, et al. (2013). Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke A Consensus Statement. Stroke 44(9): 2650-2663. DOI: 10.1161/strokeaha.113.001972. Go to original source... Go to PubMed...
    39. Zvolský M (2012). Hospitalizovaní a zemřelí na cévní nemoci mozku v ČR v letech 2003-2010 [Cerebrovascular diseases - hospitalized patients and deaths in the Czech Republic in 2003-2010]. Praha: Ústav zdravotnických informací a statistiky.

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content